Inventor · disambiguated record
Robert Neil Hunter, Iii
Also filed as: HUNTER III ROBERT N · HUNTER III ROBERT NEIL · HUNTER ROBERT · HUNTER ROBERT N
14 granted patents·6 pending applications·613 citations·filing 1998–2023
93Inventor score
Files withSMITHKLINE BEECHAM CORP8INTARCIA THERAPEUTICS INC3GLAXO WELLCOME INC2BROWN MATTHEW L1DREWRY DAVID HAROLD1
Top patents by PatentIndex Score
20 records- 0197US6369086B1Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Apr 9, 2002·213 cites·18 claims
- 0296US6268391B1Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinasesGLAXO WELLCOME INC·Filed 1998·Granted Jul 31, 2001·238 cites·26 claims
- 0395US7105529B2Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effectsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 12, 2006·64 cites·5 claims
- 0490US11840559B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·1 cites·19 claims
- 0587US11214607B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2019·Granted Jan 4, 2022·3 cites·20 claims
- 0687US6541503B2Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Apr 1, 2003·22 cites·17 claims
- 0784US10501517B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2017·Granted Dec 10, 2019·4 cites·61 claims
- 0881US7189712B21,3-Oxazole compounds for the treatment of cancerSMITHKLINE BEECHAM CORP·Filed 2003·Granted Mar 13, 2007·13 cites·5 claims
- 0980US2024239861A1Glucagon-receptor selective polypeptides and methods of use thereofI2O THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1079US6964977B2Oxindole derivativesSMITHKLINE BEECHAM CORP·Filed 2001·Granted Nov 15, 2005·10 cites·9 claims
- 1178US6387919B1Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitorsGLAXO WELLCOME INC·Filed 1998·Granted May 14, 2002·34 cites·13 claims
- 1276US7071217B2Substituted oxindole derivatives as tyrosine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Jul 4, 2006·8 cites·10 claims
- 1368US12486254B2Uracil derivatives for stimulating read-through of premature termination codonsSOUTHERN RES INST·Filed 2023·Granted Dec 2, 2025·0 cites·2 claims
- 1468US9441023B2Peptide YY analogsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Sep 13, 2016·1 cites·38 claims
- 1565US7329678B2Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2004·Granted Feb 12, 2008·2 cites·17 claims
- 1663US2024365736A1Compositions and methods for targeted degradation of proteins in a plant cellOERTH BIO LLC·Filed 2022·Application pending·0 cites
- 1748US2005282810A1Oxindole derivativesHARRIS PHILIP A·Filed 2005·Application pending·0 cites
- 1842US2007142437A1Chemical compoundsBROWN MATTHEW L·Filed 2007·Application pending·0 cites
- 1938US2008293716A1Chemical CompoundsSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 2036US2008275062A1Chemical CompoundsDREWRY DAVID HAROLD·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →